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1. Introduction 2. Materials and methods 
Recent evidence from several aboratories has indi- 
cated the presence of at least three long chain triglyce- 
ride hydrolases in the post-heparin plasma of normoli- 
pidemic subjects and laboratory animals [l-7]. These 
triglyceride hydrolases have the following properties: 
1) Lipoprotein lipase C-I (LPk_I) is present in 
post-heparin plasma but not in adipose tissue from nor- 
mal controls or post-heparin plasma from subjects 
with Type I hyperlipoproteinemia. LP&_I is activated 
by serum or C-I (one of the apolipoprotein polypep- 
tides of lipoprotein C) but not C-II and is inhibited by 
NaCl and protamine sulfate [7]. 
2) Lipoprotein lipase C-II (LPk& is present in 
post-heparin plasma and adipose tissue [7-lo]. LPLc_II 
is activated by serum or C-II but not C-I and is 
inhibited by NaCl and protamine sulfate. 
3) A third triglyceride lipase (TGL) differs from the 
foregoing two lipases in that it is insensitive to inhi- 
bition by protamine sulfate and 1 M NaCl [ 1,2]. TGL 
is believed to be secreted from liver [5] and is not 
activated by serum or apolipoprotein cofactors [ 151 ; 
LPk_II [6] and TGL [4-61, but not LPk_1 
have been isolated by heparin-sepharose chromato- 
graphy. The present report describes the isolation of 
all three lipases by heparin-sepharose chromatography 
of post-heparin plasma from normal controls, and 
demonstrates that the 1.5 M NaCl eluate which 
contains LPk_rI [4-61 also exhibits LPk_l activity 
following desalting of this fraction. 
2. I. Source of post-heparin plasma 
Post-heparin plasma was obtained from healthy 
donors who had fasted overnight (1,4- 16hr). Blood 
was drawn into iced plastic bags containing l/50 vol of 
4% sodium citrate 30 min after intravenous admini- 
stration of 10 000 units of hepatin sodillm (Upjohn Co., 
Kalamazoo, Michigan). Plasma was separated by 
centrifugation (4,500 rev/min) at 0°C and stored at 
-15°C. 
2.2. Isolation of LPL,, and LPL,, by Sephadex 
Gl 00 chromatography 
A preparation containing LPk., and LPh_II, 
which had been isolated as described previously [ Ill, 
was applied to a column (1.5 X 100 cm) containing 
Sephadex G-1 00 equilibrated with 0.05 M 
N&OH-NH4Cl buffer, pH 8.5. Additional buffer 
(4°C) was applied at the rate of 20-25 ml/hr and the 
eluate was collected in 2.0-ml fractions. Each fraction 
was analyzed for protein [ 121 and lipolytic activity 
using [14 C] -triolein activated by serum, C-I or C-II. 
2.3. Isolation of LPL,,, LPL,, and TGL by heparin- 
Sepharose chromatography 
Heparin-Sepharose column chromatography was 
performed according to the procedure described by 
Boberg, et al. [6] . Small columns (0.4 X 10 cm) 
were filled to a height of 2.5 cm with heparin-Sepharose, 
prepared according to the mqthod of Egelrud and 
North-Holland Publishing Company - Amsterdam 1 
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Olivecrona [ 131 and equilibrated with 5 mM Verona1 
buffer, pH 7.4, containing 0.3 M NaCl. An aliquot 
(4.0 ml) of post-heparin plasma, diluted with an 
equal volume of 5.0 mM Verona1 buffer containing 
0.3 M NaCI, was applied to the column. The column 
was eluted sequentially with 8.0 ml of Verona1 buffer 
containing 0.3 M NaCl, 8.0 ml of Verona1 buffer 
containing 0.72 M NaCl (elution of TGL) followed by 
an additional 6.0 ml of this solution, and 8.0 ml of 
1.5 M NaCl-Verona1 buffer (elution of LPk_I and 
LPk.II). Each fraction was assayed for lipolytic 
activity using [ r4 C] -triolein activated by serum, C-I 
or C-II, as well as for response to protamine sulfate 
(3.0 mgjml). 
Fractions eluted with Verona1 buffer containing 
either 0.72 M NaCl or 1.5 M NaCl were desalted by 
chromatography on Sephadex G-25 (0.4 X 10 cm 
columns, filled to a height of 5-6 cm) equilibrated 
with Verona1 buffer. 
2.4. Assays of lipolytic activity 
Preparation of the substrate containing [ 14C] - 
triolein has been described previously [7] , except that 
Triton X-l 00 was substituted for gum arabic as an 
emulsifier. Fatty acid was extracted by the method of 
Schotz et al. [ 141. Lipolytic activity was also 
measured in the presence of protamine sulfate (3.0 mg/ 
ml), according to the procedure described by Krauss 
et al. [I]. 
2.5. Isolation and characterization of C-I and C-II 
C-I and C-II polypeptides were isolated and 
characterized by the methods described previously 
1161. 
3. Results and discussion 
Our earlier studies have demonstrated the presence 
of two lipoprotein lipases, LPk_I and LPL,_,,, in 
post-heparin plasma normal controls [IS] . Fig. 1 shows 
the elution pattern of these two LPLs on Sephadex 
G-100 chromatography, and their polypeptide acti- 
vation characteristics. LPk_I and LPk_II are inacti- 
vated by 1 M NaCl and protamine sulfate (3 mg/ml) 
either when preincubated with the inhibitor or when 
the inhibitor is added during incubation of the assay 
mixture. LPk_, exhibited greater sensitivity than 
LPk_II to NaCl inhibition. 
In the present study, TGL was eluted from 
heparin-sepharose columns prior to the two LPLs, 
required no serum cofactor, and was insensitive to 
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Fig.1. Separation of LPLC_I (first fraction eluted), LPLC_II and lipoprotein C polypeptides by Sephadex G-100 chromatography. 
The sodium citrate eluate from calcium phosphate gel chromatography of post-heparin plasma from normal controls was applied 
to the column, and eluted as described under Methods. Each &ate fraction (2.0 ml) was analyzed for protein and lipolytic 
activity. Assays for lipolytic activity were performed using [‘*Cl -triolein (22 000 dpm) emulsified in Triton X-100,5 wmol of C-I 
or C-II, 10 pg of phosphatidylcholine, 60 mg of albumin and 25 ctmole of ammonium sulfate at pH 8.5. Incubations at 37°C were 
for 1 hr. 
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Table 1 
Characteristics of lipolytic activities present in human post-heparin plasma 
Enzyme preparation Lipolytic activity Protamine sulfate*** 
rmol/ml enzyme/h1 
Activator added 
LPLC_I * 
LPLc_n * 
0.72 M** NaCl-Verona1 
buffer fraction 
None Serum C-I C-II Percent of control 
0.02 0.80 1.20 0.04 6 
0.01 1.02 0.03 0.81 14 
4.97 5.42 4.03 5.26 123 
0.72 M** NaCl-Verona1 
buffer fraction after 
Sephadex G25 chromatography 
5.10 4.98 4.60 5.12 102 
1.5 M** NaCl-Verona1 
buffer fraction 
0.65 6.09 0.80 10.80 16 
1.5 M** NaCl-Verona1 
buffer fraction after 
Sephadex G25 chromatography 
0.67 3.43 7.85 1.01 11 
Assay mixtures (1.0 ml total vol) contained 0.1 ml of enzyme solution, either 0.05 ml of serum or 
10 pg C-I or C-II polypeptide and 0.5 ml of substrate containing 10 rmole of [‘“Cl -triolein emulsified witli 
Triton X-100. 
*These enzyme fractions were obtained by Sephadex G-100 chromatography. 
**These fractions were obtained by heparin-sepharose chromatography. 
***Protamine sulfate was added to the enzyme solution 10 min prior to beginning the 1-hr incubation 
(at 27°C) with the [“‘Cl -triolein substrate. Values are presented as percent of control lipolytic 
activity: lipolytic activity in assay containing protamine sulfate/control lipolytic activity. 
protamine sulfate (table 1). These data are in agree- 
ment with those reported by Boberg et al. [6]. 
Lipolytic activity in the 1.5 M NaCl-Verona1 buffer 
fraction (containing LPk_I and LPk_II) was activated 
by the addition of serum or C-II and was inhibited by 
protamine sulfate (table 1). Although disc gel electro- 
phoresis on 7% polyacrylamide containing 8 M urea 
demonstrated protein bands characteristic of LPI+I 
as well as LP&_I1, C-I activation was not detected 
prior to desalting this fraction by chromatography on 
Sephadex G-25. Furthermore, activation by C-I was 
somewhat less (50-70%) than that observed in a 
LP& preparation isolated by Sephadex G-100 
chromatography, suggesting that the salt inactivation 
of LPk_l was only partially reversible under these 
conditions. In most but not all instances, the desalting 
process resulted in loss of activity in LPk_II. 
These data provide additional evidence indicating 
that post-heparin plasma contains at least three 
triglyceride hydrolases. Heparin-sepharose column 
chromatography provides a simple one-step procedure 
for separating TGL from LP&_, and LPk_,, 
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